PT  - JOURNAL ARTICLE
AU  - Esther Walton
AU  - Fabio Bernardoni
AU  - Victoria-Luise Batury
AU  - Klaas Bahnsen
AU  - Sara Larivière
AU  - Giovanni Abbate-Daga
AU  - Susana Andres-Perpiña
AU  - Lasse Bang
AU  - Amanda Bischoff-Grethe
AU  - Samantha J Brooks
AU  - Iain C Campbell
AU  - Giammarco Cascino
AU  - Josefina Castro-Fornieles
AU  - Enrico Collantoni
AU  - Federico D’Agata
AU  - Brigitte Dahmen
AU  - Unna N. Danner
AU  - Angela Favaro
AU  - Jamie D Feusner
AU  - Guido KW Frank
AU  - Hans-Christoph Friederich
AU  - John L Graner
AU  - Beate Herpertz-Dahlmann
AU  - Andreas Hess
AU  - Stefanie Horndasch
AU  - Allan S Kaplan
AU  - Lisa-Katrin Kaufmann
AU  - Walter H Kaye
AU  - Sahib S Khalsa
AU  - Kevin S LaBar
AU  - Luca Lavagnino
AU  - Luisa Lazaro
AU  - Renzo Manara
AU  - Amy E Miles
AU  - Gabriella F. Milos
AU  - Alessio Maria Monteleone
AU  - Palmiero Monteleone
AU  - Benson Mwangi
AU  - Owen O’Daly
AU  - Jose Pariente
AU  - Julie Roesch
AU  - Ulrike H Schmidt
AU  - Jochen Seitz
AU  - Megan E Shott
AU  - Joe J Simon
AU  - Paul A.M. Smeets
AU  - Christian K Tamnes
AU  - Elena Tenconi
AU  - Sophia I. Thomopoulos
AU  - Annemarie A. van Elburg
AU  - Aristotle N Voineskos
AU  - Georg G von Polier
AU  - Christina E Wierenga
AU  - Nancy L Zucker
AU  - Joseph A King
AU  - Paul M. Thompson
AU  - Laura A Berner
AU  - Stefan Ehrlich
TI  - Brain Structure in Acutely Underweight and Partially Weight-Restored Individuals with Anorexia Nervosa - A Coordinated Analysis by the ENIGMA Eating Disorders Working Group
AID  - 10.1101/2021.10.18.21264728
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.10.18.21264728
4099  - http://medrxiv.org/content/early/2021/10/26/2021.10.18.21264728.short
4100  - http://medrxiv.org/content/early/2021/10/26/2021.10.18.21264728.full
AB  - The pattern of structural brain abnormalities in anorexia nervosa (AN) is still not well understood. While several studies report substantial deficits in grey matter volume and cortical thickness in acutely underweight patients, others find no differences, or even increases in patients compared with healthy controls. Recent weight regain before scanning may explain some of this heterogeneity across studies. To clarify the extent, magnitude, and dependencies of grey matter changes in AN, we conducted a prospective, coordinated meta-analysis of multicenter neuroimaging data. We analyzed T1-weighted structural MRI scans assessed with standardized methods from 685 female AN patients and 963 female healthy controls across 22 sites worldwide. In addition to a case-control comparison, we conducted a three-group analysis comparing healthy controls to acutely underweight AN patients (n = 466), and to those in treatment and partially weight-restored (n = 251). In AN, reductions in cortical thickness, subcortical volumes, and, to a lesser extent, cortical surface area, were sizable (Cohen’s d up to 0.95), widespread and co-localized with hub regions. Highlighting the effects of undernutrition, these deficits associated with lower BMI in the AN sample and were less pronounced in partially weight-restored patients. Notably, the effect sizes observed for cortical thickness deficits in acute AN are the largest of any psychiatric disorder investigated in the ENIGMA consortium to date. These results confirm the importance of considering weight loss and renutrition in biomedical research on AN and underscore the importance of treatment engagement to prevent potentially long-lasting structural brain changes in this population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Carus Promotionskolleg (KB), the Ministerio de Igualdad, Spain (grant number 234/09) and by the Generalitat de Catalunya (2009 SGR 1119) (SA), NIH R21MH86017, NIH R01MH113588 (ABG), Biomedical Research Centre (BRC) UK (ICC), the Alicia Koplowitz Foundation (FAK) (DN040546) and by the Generalitat de Catalunya 2017SGR4881 (JCF), German Ministry for Education and Research (grants 01GV0602 and 01GV0623) (BD), NIMH R01MH105662, NIMH R01MH093535 (JDF), NIMH K23MH080135, R01MH096777 (GKWF), NIH RC1MH088678 (JLG), German Ministry for Education and Research (grants 01GV0602 and 01GV0623) (BHD), the CAMH AFP Innovation Fund (ASK), Swiss Anorexia Nervosa Foundation (project no. 19-12), the Palatin Foundation, and the Gottfried and Julia Bangerter-Rhyner-Foundation (LKK), NIH R01MH042984- 17A1, Price Foundation, NIH R01MH113588 (WHK), NIMH K23MH112949 (SSK), NIH RC1MH088678 (KSL), the Carlos III Research Institute of the Spanish Ministry of Health, FIS PI040829 and by the Generalitat de Catalunya (2009 SGR 1119) (LL), the CAMH AFP Innovation Fund (AEM), Swiss Anorexia Nervosa Foundation (project no. 19-12), the Palatin Foundation, and the Gottfried and Julia Bangerter-Rhyner-Foundation (GFM), Biomedical Research Centre (BRC) UK (OOD), Biomedical Research Centre (BRC) UK (UHS), German Ministry for Education and Research (grants 01GV0602 and 01GV0623) (JS), NIMH K23MH080135, R01MH096777 (MES), DFG: SI 2087/2-1, BR 4852/1-1, Swiss Anorexia Nervosa Foundation: 57-16 (JJS), Research Council of Norway (#288083, #223273); South-Eastern Norway Regional Health Authority (#2019069, #2021070, #500189) (CKT), the CAMH AFP Innovation Fund (ANV), German Ministry for Education and Research (grants 01GV0602 and 01GV0623) (GGvP), NIH R21MH86017, R01MH113588 (CEW), NIH RC1MH088678 (NLZ), NIH RC1MH088678 (JAK), a National Institute of Health Research (NIHR) Senior Investigator Award (US), the NIHR Mental Health Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and Kings College London (ICC, US and OOD), K23MH118418; NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (LAB), and SFB 940, DFG: EH 367/5-1, EH 367/7-1 and the Swiss Anorexia Nervosa Foundation (SE). This work is further supported by the European Unions Horizon 2020 research and innovation programme (EarlyCause, grant number 848158, to EW). The ENIGMA Working Group acknowledges the NIH Big Data to Knowledge (BD2K) award for foundational support and consortium development (U54 EB020403 to Paul M. Thompson).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participating sites obtained approval from local institutional review boards and ethics committees, and all study participants provided written informed consent (SM section 1.1). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.